Pfizer and Moderna are expanding the size of their vaccine trials for children 5 to 11 years old, seeking to better detect very rare heart issues among those vaccinated.
The major vaccine makers ar… [+2472 chars]
Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-Olds – HuffPost
